Sahni is DG, CSIR

sahGirish Sahni, who was Director, CSIR-Institute of Microbial Technology, Chandigarh, assumed charge as DG, CSIR and Secretary, Department of Scientific & Industrial Research. He is internationally recognized for his research as he authored papers published in high impact journals and has national and international patents to his credit. Specialised in Protein Engineering, Molecular Biology and Biotechnology he contributed in protein cardiovascular drugs ‘clot busters’ and their action in the human body. His team developed a life-saver thrombolytic drug (Clot-specific streptokinase), India’s first bio-therapeutic molecule which is not a bio-similar. This life-saver drug has been patented and licensed to a US Pharma company and its launch is in 2016. Recently, his team developed fourth-generation ‘anti-thrombotic’ clot busters – the first of its kind in the world.

Medaram Jathara

Connect with us

© 2012 - 2016 VIL Media Pvt Ltd. All rights reserved,
Contents of are copyright protected.Copy and/or reproduction and/or re-use of contents or any part thereof,
without consent of VIL Media is illegal.Such persons will be prosecuted.